Evaluation of the clinical outcomes of the Test and Treat strategy to implement Treat All in Nigeria: Results from the Nigeria Multi-Center ART Study

In December 2016, the Nigerian Federal Ministry of Health updated its HIV guidelines to a Treat All approach, expanding antiretroviral therapy (ART) eligibility to all individuals with HIV infection, regardless of CD4+ cell count, and recommending ART be initiated within two weeks of HIV diagnosis (i.e., the Test and Treat strategy). The Test and Treat policy was first piloted in 32 local government areas (LGAs). The primary objective of this study was to evaluate the clinical outcomes of adult patients initiated on ART within two weeks of HIV diagnosis during this pilot. We conducted a retrospective cohort analysis of patients who initiated ART within two weeks of new HIV diagnosis between October 2015 and September 2016 in eight randomly selected LGAs participating in the Test and Treat pilot study. 2,652 adults were newly diagnosed and initiated on ART within two weeks of HIV diagnosis. Of these patients, 8% had documentation of a 12-month viral load measurement, and 13% had documentation of a six-month viral load measurement. Among Test and Treat patients with a documented viral load, 79% were suppressed (≤400 copies/ml) at six months and 78% were suppressed at 12 months. By 12 months post-ART initiation, 34% of the patients who initiated ART under the Test and Treat strategy were lost to follow-up. The median CD4 cell count among patients initiating ART within two weeks of HIV diagnosis was 323 cells/mm3 (interquartile range, 161–518). While randomized controlled trials have demonstrated that Test and Treat strategies can improve patient retention and increase viral suppression compared to standard of care, these findings indicate that the effectiveness of Test and Treat in some settings may be far lower than the efficacy demonstrated in randomized controlled trials. Significant attention to the way Test and Treat strategies are implemented, monitored, and improved particularly related to early retention, can help expand access to ART for all patients.

[1]  T. Klimkait,et al.  Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial , 2018, JAMA.

[2]  N. Ware,et al.  Retention in Differentiated Care: Multiple Measures Analysis for a Decentralized HIV Care and Treatment Program in North Central Nigeria , 2018, Journal of AIDS & clinical research.

[3]  A. Grimwood,et al.  The effectiveness and cost-effectiveness of 3- vs. 6-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART-refill groups in Zimbabwe: study protocol for a pragmatic, cluster-randomized trial , 2018, Trials.

[4]  T. Decroo,et al.  Effect of Community ART Groups on retention-in-care among patients on ART in Tete Province, Mozambique: a cohort study , 2017, BMJ Open.

[5]  J. Pape,et al.  Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial , 2017, PLoS medicine.

[6]  P. Ehrenkranz,et al.  Simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE): protocol for a randomised evaluation , 2017, BMJ Open.

[7]  F. Odekunle,et al.  The impact of the US president’s emergency plan for AIDS relief (PEPFAR) HIV and AIDS program on the Nigerian health system , 2016, The Pan African medical journal.

[8]  S. Odafe,et al.  Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012 , 2016, PloS one.

[9]  M. Fox,et al.  Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial , 2016, PLoS medicine.

[10]  T. Bärnighausen,et al.  Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness , 2016, Journal of the International AIDS Society.

[11]  P. Kaleebu,et al.  Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda , 2015, AIDS Research and Therapy.

[12]  H. Lane,et al.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. , 2015, The New England journal of medicine.

[13]  G. Patten,et al.  Outcomes from the implementation of a counselling model supporting rapid antiretroviral treatment initiation in a primary healthcare clinic in Khayelitsha, South Africa , 2015, Southern African journal of HIV medicine.

[14]  Federal Ministry of Health (Nigeria).  Integrated national guidelines for HIV prevention, treatment, and care: Chapters 5 and 6 , 2015 .

[15]  J. Sankalé,et al.  Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004–2012 , 2015, African journal of laboratory medicine.

[16]  R. Sahabo,et al.  Implementation and Operational Research: Evaluation of Swaziland's Hub-and-Spoke Model for Decentralizing Access to Antiretroviral Therapy Services , 2015, Journal of acquired immune deficiency syndromes.

[17]  M. Laga,et al.  Four‐year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique , 2014, Tropical medicine & international health : TM & IH.

[18]  Jeffrey W. Eaton,et al.  HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa , 2012, PLoS medicine.

[19]  Richard D Moore,et al.  Comparing different measures of retention in outpatient HIV care , 2012, AIDS.

[20]  W. Blattner,et al.  Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors , 2010, PloS one.

[21]  A. Abimiku.  Building laboratory infrastructure to support scale-up of HIV/AIDS treatment, care, and prevention: in-country experience. , 2009, American journal of clinical pathology.

[22]  James Curran,et al.  Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach , 2005 .

[23]  C. Giaquinto,et al.  Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002. , 2002, IAPAC monthly.